home / stock / mist / mist quote
Last: | $ |
---|---|
Change Percent: | -3.27% |
Open: | $21.82 |
Close: | $21.02 |
High: | $21.8298 |
Low: | $20.30 |
Volume: | 395,676 |
Last Trade Date Time: | 02/12/2020 04:42:13 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $21.82 | $21.02 | $21.8298 | $20.30 | 395,676 | 02-12-2020 |
$ | $21.52 | $21.73 | $21.85 | $21.52 | 309,055 | 02-11-2020 |
$ | $21.69 | $21.73 | $21.997 | $21.32 | 37,916 | 02-10-2020 |
$ | $21.64 | $21.45 | $21.73 | $21.01 | 75,618 | 02-07-2020 |
$ | $22.49 | $21.96 | $22.49 | $21.60 | 3,727 | 02-06-2020 |
$ | $21.26 | $22.50 | $23.245 | $20.705 | 63,168 | 02-05-2020 |
$ | $22.00 | $21.24 | $22.00 | $20.5101 | 13,139 | 02-04-2020 |
$ | $18.5201 | $21.86 | $21.96 | $18.51 | 31,285 | 02-03-2020 |
$ | $21.6269 | $22.05 | $22.1999 | $21.2507 | 5,400 | 01-31-2020 |
$ | $21.57 | $22.00 | $22.50 | $20.70 | 40,625 | 01-30-2020 |
$ | $21.20 | $21.87 | $22.50 | $20.5751 | 27,067 | 01-29-2020 |
$ | $21.31 | $21.50 | $21.50 | $20.60 | 16,716 | 01-28-2020 |
$ | $20.65 | $21.36 | $21.50 | $20.21 | 17,923 | 01-27-2020 |
$ | $21.27 | $21.33 | $21.41 | $19.85 | 49,514 | 01-24-2020 |
$ | $21.50 | $21.48 | $21.50 | $19.7301 | 41,579 | 01-23-2020 |
$ | $19.72 | $21.69 | $21.95 | $18.72 | 82,443 | 01-22-2020 |
$ | $18.52 | $19.81 | $19.81 | $18.00 | 71,418 | 01-21-2020 |
$ | $18.60 | $18.47 | $18.8492 | $18.11 | 10,121 | 01-20-2020 |
$ | $18.60 | $18.47 | $18.8492 | $18.11 | 10,121 | 01-17-2020 |
$ | $18.00 | $18.59 | $18.9599 | $17.65 | 42,543 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Milestone Pharmaceuticals Inc. Company Name:
MIST Stock Symbol:
NYSE Market:
MONTREAL and CHARLOTTE, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company...
MONTREAL and CHARLOTTE, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will present data on etripami...
MONTREAL and CHARLOTTE, N.C., April 08, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced new clinical data demonstrating real-...